Onco Detect News Today

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2023 Earnings Call Transcript February 21, 2024 Exact Sciences Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.53. Exact Sciences Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome […]

Exact Sciences Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.53.

EXAS earnings call for the period ending June 30, 2023.